Key Takeaway: While both medications target the GLP-1 pathway to reduce hunger, tirzepatide adds a second pathway (GIP) to further support metabolic health
SAR425899, which has yielded early promising results regarding weight and hyperglycemia, 51,52 has undergone a phase 2 study, where it was administered in combination with metformin vs, placebo plus metformin and liraglutide plus metformin, in diabetic obese patients (NCT02973321)
Instead, focus on a balanced diet with plenty of fruits, vegetables, lean proteins, and whole grains to help support your treatment plan
A case for the evolution from commensalism to pathogenicity and possibly back again: lessons learned from the human-adapted neisseria species
doi: 10.1016/j.omtm.2022.09.014 23 BankheadPLoughreyMBFernandezJADombrowskiYMcArtDGDunnePDet al
It delays stomach emptying and slows intestinal motility resulting in a decreased desire for food and a greater sense of contentment after meals